![Eva Lilienberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 93 611 $ al 31/08/2026
Ms. Eva Lilienberg is an Independent Director at AlzeCure Pharma AB and a Chief Executive Officer at Kapitel Tre AB. She is on the Board of Directors at AlzeCure Pharma AB.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ALZECURE PHARMA AB 0,09 % | 31/12/2025 | 121.630 ( 0,09 % ) | 93 611 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALZECURE PHARMA AB | Director/Miembro de la Junta | 01/01/2021 |
Kapitel Tre AB
 Kapitel Tre AB Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Kapitel Tre AB
Kapitel Tre AB Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Commercial Services |
AlzeCure Pharma AB
 AlzeCure Pharma AB BiotechnologyHealth Technology Engages in research, development, manufacture and sale of pharmaceutical products for neuro diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
